Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06183281 · ClinicalTrials.gov registry record · NA
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
A NA study of Chronic Pain, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 586
- Enrollment target
- 2
- Study locations
NCT06183281: Recruiting NA study of Chronic Pain, sponsored by University of California, San Francisco.
NCT06183281 is a NA study of Chronic Pain that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 586 participants, below the 770-participant average among 301 other Chronic Pain trials with a reported enrollment target (24% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06183281, a NA study of Chronic Pain, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 586 participants
- Enrollment target
- 2
- Study locations
Study Summary
INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.
Primary Outcome
The PEG Pain Screening Tool is a validated, self-reported 3-question survey assessing pain severity, the extent to which pain interferes with enjoyment of life, and the extent to which pain interferes with general activity. Possible scores for each question range from 0 (no pain, no interference) to 10 (worst possible pain, worst possible interference). The average of scores from the three questions yields the PEG score. Change = (PEG score at time point - PEG score at baseline)
Conditions Studied
Interventions
- BEHAVIORAL CBT, Mindfulness, and Movement
Study Locations (2)
California
- San Francisco General Hospital - San Francisco
- UCSF Adult Primary Care Mt. Zion Clinic - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 586 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2027-08-01 |
| Phase | NA |
What NCT06183281 shows while recruiting
NCT06183281 is an interventional study that assigns participants to a tested intervention. The registered 586 participants enrollment target is mid-sized for trials with a published cap, below the 770-participant average among 301 other Chronic Pain trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which CBT, Mindfulness, and Movement is the first listed.
NCT06183281 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06183281 about?
NCT06183281 is a clinical study titled "Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity". INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023...
What is the current status of trial NCT06183281?
This trial is currently recruiting. It is a NA study. The enrollment target is 586 participants. The study started on 2025-04-15. Estimated completion is 2027-08-01.
What conditions does trial NCT06183281 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT06183281?
The interventions under investigation include: CBT, Mindfulness, and Movement (BEHAVIORAL).
Who is sponsoring clinical trial NCT06183281?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06183281 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06183281's enrollment target sits among peer trials
586 17th of 301 higher than 285 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
- NCT06976203 · 586 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- NCT06976216 · 586 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI